Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 17,442 |
|
|||||
| News | - | ||||||
| Day High | 2.88 | Low High |
|||||
| Day Low | 2.74 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.03 | 1.07% | 2.84 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.85 | 2.74 | 2.88 | 2.84 | 2.81 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 207 | 17,442 | US$ 2.81 | US$ 49,062 | - | 2.00 - 70.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:54:03 | 1 | US$ 2.88 | USD |
MyMD Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.94M | 2.09M | - | 0 | -8.22M | -3.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MyMD Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/07/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 10:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 08:15 | Business Wire | MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum.. |
| 2/14/2024 | 14:13 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 2/14/2024 | 10:27 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2/13/2024 | 15:57 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/13/2024 | 10:45 | Business Wire | MyMD Pharmaceuticals Announces Reverse Stock Split to.. |
| 12/06/2023 | 08:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/06/2023 | 08:15 | Business Wire | MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical.. |
| 10/19/2023 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/19/2023 | 08:00 | Business Wire | MyMD Announces Preclinical Study Results Showing Novel.. |
| 10/13/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYMD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.50 | 2.9324 | 2.50 | 2.72 | 46,174 | 0.34 | 13.60% |
| 1 Month | 2.40 | 3.50 | 2.00 | 2.61 | 651,045 | 0.44 | 18.33% |
| 3 Months | 4.35 | 4.50 | 2.00 | 3.27 | 428,547 | -1.51 | -34.71% |
| 6 Months | 12.687 | 12.903 | 2.00 | 6.66 | 977,275 | -9.85 | -77.61% |
| 1 Year | 57.00 | 70.50 | 2.00 | 18.39 | 818,392 | -54.16 | -95.02% |
| 3 Years | 123.60 | 298.50 | 2.00 | 53.07 | 419,780 | -120.76 | -97.70% |
| 5 Years | 162.90 | 298.50 | 2.00 | 57.62 | 438,322 | -160.06 | -98.26% |
MyMD Pharmaceuticals Description
| MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. |
